An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

Male patients with ER+ breast cancer tend to have grade 2 or 3 tumors, stage II or III disease, and progesterone receptor-positivity compared to female patients.

Ogletree Deakins’ T. Scott Kelly discusses the strategy of the firm’s Workforce Analytics and Compliance Practice Group, the ...

This comprehensive report delivers insights into market trends, drivers, and forecasts, covering recent tariff developments ...

AbbVie's Phase 3 VERONA trial in HR-MDS showed no overall survival benefit for venetoclax-azacitidine; existing uses of ...

Effective maintenance of microgrids involves proactive strategies like condition-based monitoring and predictive analytics to ...

The global STD testing market is set for significant growth, propelled by rising STD cases, tech innovations, and heightened public health awareness. Projected to grow from $11.03 billion in 2025 to ...

Sessions and posters at the 2025 European Hematology Association Congress evaluated the potential and real-world practices of using artificial intelligence (AI) to predict and improve outcomes for ...

The proportion of patient harms associated with medical procedures, treatment, and contact with healthcare systems rose by 59 ...

Deep Learning, Personalized Pharmacotherapy, Pregnancy, Psychiatric Disorders, Electronic Health Records, Drug Efficacy Share and Cite: Filippis, R. and Foysal, A. (2025) Deep Learning for ...

The genomic biomarkers market is experiencing rapid growth, driven by advancements in precision medicine, early disease ...